UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056376
Receipt number R000064403
Scientific Title Investigating the Effectiveness of a Combined Intervention Based on a Nurse-Led Multidimensional Assessment for the Management of Postoperative Adverse Effects of Breast Cancer.
Date of disclosure of the study information 2024/12/10
Last modified on 2024/12/06 10:19:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A nurse-led study on comprehensive management of postoperative side effects of breast cancer

Acronym

A nurse-led study on comprehensive management of postoperative side effects of breast cancer

Scientific Title

Investigating the Effectiveness of a Combined Intervention Based on a Nurse-Led Multidimensional Assessment for the Management of Postoperative Adverse Effects of Breast Cancer.

Scientific Title:Acronym

Investigating the Effectiveness of a Combined Intervention Based on a Nurse-Led Multidimensional Assessment for the Management of Postoperative Adverse Effects of Breast Cancer.

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Breast surgery Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To examine the effectiveness of nurse-led, multidisciplinary assessment-based management of postoperative side effects in postoperative breast cancer patients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

BPI pain intensity

Key secondary outcomes

Disability(Quick DASH,BPI interference),Central sensitization-related symptoms,Pain catastorphizing(PCS 6),anxiety(GAD 2),depression(PHQ 2),Health related quality of life(EQ 5D 5L),physical activity(GPAQ),public health care costs and other costs.Muscle strength,upper limb volume,and shoulder joint range of motion testing


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Female

Key inclusion criteria

Patients diagnosed with breast cancer and undergoing/receiving surgery at the Breast Surgery Department of Izumi City General Medical Center
(1) Patients aged 20-80 years old who have been diagnosed with breast cancer
(2) Patients with Clinical stage 0-III

Key exclusion criteria

(1) Those with recurrent or metastatic cancer
2) Male patients
(3) Patients scheduled for breast reconstruction or post-reconstructive surgery
(4) Patients who received outpatient rehabilitation for upper limb symptoms after breast cancer surgery

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Masami
Middle name
Last name Shirai

Organization

Izumi City General Medical Center

Division name

Nursing Department

Zip code

594-0073

Address

4-5-1, Wake-Cho, Izumi-shi, Osaka, Japan

TEL

0725-41-1331

Email

masami.shirai@tokushukai.jp


Public contact

Name of contact person

1st name Masami
Middle name
Last name Shirai

Organization

Izumi City General Medical Center

Division name

Nursing Department

Zip code

594-0073

Address

4-5-1, Wake-Cho, Izumi-shi, Osaka, Japan

TEL

0725-41-1331

Homepage URL


Email

masami.shirai@tokushukai.jp


Sponsor or person

Institute

Izumi City General Medical Center

Institute

Department

Personal name

Masami Shirai


Funding Source

Organization

None.

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Breast Care Senshu Clinic

Name of secondary funder(s)

None.


IRB Contact (For public release)

Organization

Tokushukai Group Joint Ethics Review Committee

Address

1-3-1, Kudan-minami, Chiyoda-ku, Tokyo

Tel

03-3263-4801

Email

mirai-ec1@mirai-iryo.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 12 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 11 Month 08 Day

Date of IRB

2024 Year 11 Month 18 Day

Anticipated trial start date

2024 Year 11 Month 21 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The purpose of this study is to examine the effectiveness of nurse-led, multidisciplinary assessment-based postoperative side-effect management in postoperative breast cancer patients.


Management information

Registered date

2024 Year 12 Month 06 Day

Last modified on

2024 Year 12 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064403